Al Hammadi Co. for Development and Investment reported a net profit of SAR 105.6 million for the first nine months of 2015, an 11 percent jump year-on-on-year (YOY) due to higher revenue, expanding its services to patients, as well as the launch of Al-Hammadi Al-Suweidi Hospital in August.
| Item | 9m 2014 | 9m 2015 | Change |
|---|---|---|---|
| Revenues | 352.53 | 403.64 | 14.5 % |
| Gross Income | 153.13 | 172.17 | 12.4 % |
| Operating Income | 96.43 | 103.17 | 7.0 % |
| Net Income | 95.24 | 105.58 | 10.9 % |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.60 | 0.66 | 10.9 % |
The Saudi-listed company, which invests in hospitals, reported a net profit of SAR 27.7 million during Q3-2015, marking a nine percent increase compared to the same quarter of the previous year. However, net profit dropped 25 percent compared to the previous quarter on seasonal impact and higher operating costs.
| Item | Q3 2014 | Q3 2015 | Change |
|---|---|---|---|
| Revenues | 108.83 | 136.80 | 25.7 % |
| Gross Income | 44.74 | 57.97 | 29.6 % |
| Operating Income | 24.77 | 31.92 | 28.8 % |
| Net Income | 25.42 | 27.69 | 8.9 % |
| Average Shares | 160.00 | 160.00 | - |
| EPS (Riyals) | 0.16 | 0.17 | 8.9 % |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2015 | 129.48 | 6.1 % | 50.64 | (7.4 %) | 41.01 | 19.8 % | 0.26 |
| Q2 2015 | 137.36 | 12.9 % | 63.56 | 18.4 % | 36.89 | 3.6 % | 0.23 |
| Q3 2015 | 136.80 | 25.7 % | 57.97 | 29.6 % | 27.69 | 8.9 % | 0.17 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2015 | 41.90 % | 29.13 % | 25.73 % |
| Q2 2015 | 42.55 % | 28.68 % | 25.19 % |
| Q3 2015 | 42.80 % | 29.71 % | 24.29 % |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2015 | 160.00 | 0.85 | 0.79 | 8.51 |
| Q2 2015 | 160.00 | 0.86 | 0.80 | 8.27 |
| Q3 2015 | 160.00 | 0.87 | 0.81 | 8.44 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2015 | 51.53 | 55.54 | 5.14 |
| Q2 2015 | 54.13 | 58.30 | 5.61 |
| Q3 2015 | 44.33 | 47.69 | 4.57 |
2015
| Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
|---|
| Item | Q3 2015 (e) | Q3 2015 (a) | Change |
|---|---|---|---|
| Average | 31.17 | 27.69 | (11.2 %) |
| Item | Q3 2015 (e) | Q3 2015 (a) | Change |
|---|---|---|---|
| OSOOL AND BAKHEET | 25.10 | 27.69 | 10.3 % |
| AlJazira Capital | 31.40 | 27.69 | (11.8) % |
| 99Hlala Capital | 37.00 | 27.69 | (25.2) % |
| Current | |
| Market Cap (M Riyal) | 7,512.00 |
| Enterprise Value (EV) (M) | 7,510.11 |
| Shares Outstanding ((M)) | 160.00 |
| EPS ( Riyal) (TTM) | 1.79 |
| Book Value (BV) ( Riyal) | 11.58 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | 26.88 |
| P/E (TTM) | 26.27 |
| Price/book | 4.05 |
| Return on Average Assets (%) (TTM) | 11.1 |
| Return on Average Equity (%) (TTM) | 15.9 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}